Ellie’s Law
- Bill Number
- S. 1609
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-05-06: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Last Updated
- 2026-03-18T11:03:18Z
AI-Generated Summary
Purpose
The legislation aims to increase federal funding for research on unruptured intracranial aneurysms (bulging blood vessels in the brain that have not burst) at the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH). It seeks to support more comprehensive studies on a diverse group of patients to improve understanding, prevention, and treatment of this condition, which affects millions and can be life-threatening if it ruptures.
Key Provisions
- Findings Section: Outlines the scale of the problem, including:
- An estimated 6.8 million Americans (1 in 50) have unruptured brain aneurysms.
- About 30,000 ruptures occur annually, with 50% fatal and 66% of survivors facing permanent neurological damage (such as loss of movement or speech).
- Higher risks for women, African Americans, and Hispanics.
- Shares personal stories of five women (Ellie Helton, Lisa Colagrossi, Kristen Shafer Englert, Teresa Anne Lawrence, and Jennifer Sedney) who died from ruptured aneurysms, highlighting missed symptoms like severe headaches and lack of awareness.
- Notes economic costs: $2 billion in annual direct medical expenses (before insurance), with intensive care stays as the main driver; low federal research spending ($2.94 per affected person yearly); and past progress from international studies on unruptured aneurysms.
- Funding Authorization: Allocates $10 million annually to NINDS for fiscal years 2026 through 2030 (totaling $50 million) for research on unruptured aneurysms, focusing on diverse populations by age, sex, and race. Funds remain available until September 30, 2033.
- Supplement Requirement: New funds must add to, not replace, existing brain aneurysm research funding.
Significant Changes to Existing Law
This bill introduces new dedicated funding for NINDS research on unruptured aneurysms, which was not previously authorized at this level or with this specific focus on population diversity. It builds on prior international studies but does not amend existing laws directly; instead, it expands federal support beyond the current low per-person research investment.
Potential Impacts
- Government Agencies: Provides additional resources to NINDS and NIH, potentially increasing their capacity for neurological research without cutting other programs.
- Citizens: Could lead to better detection, treatment options, and awareness of aneurysm risks, benefiting the 6.8 million affected individuals, their families, and high-risk groups (e.g., women and minorities). May reduce long-term healthcare costs and fatalities from ruptures.
- International Relations: No direct impact, though it references past international studies, which could encourage global collaboration on aneurysm research.
Main Stakeholders Affected
- Patients and Families: Those with or at risk for brain aneurysms, including survivors of ruptures and loved ones, who may gain from improved research and awareness (e.g., the families of the named victims as advocates).
- Healthcare Providers: Doctors, neurologists, and emergency personnel who treat aneurysms, potentially benefiting from evidence-based guidelines.
- Researchers and Institutions: NINDS scientists and academic partners conducting studies on diverse populations.
- Advocacy Groups: Organizations focused on brain aneurysm awareness, which could see amplified efforts through increased funding.
Notable Legal, Constitutional, or Political Implications
- Legal: As an authorization bill, it requires future appropriations (actual spending approval by Congress), ensuring flexibility in budget processes. No enforcement mechanisms or penalties are included, focusing solely on research funding.
- Constitutional: Aligns with Congress's power to appropriate funds for public health under the General Welfare Clause; no challenges to individual rights or federalism issues.
- Political: Bipartisan introduction (by Senators Blumenthal (D) and Mullin (R)) honors specific victims to build public support and raise awareness. It addresses health disparities (e.g., racial and gender inequities) without mandating policy changes, potentially influencing future NIH priorities on underfunded conditions.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Sen. Blumenthal, Richard [D-CT]
Cosponsors (5)
Sen. Mullin, Markwayne [R-OK], Sen. Reed, Jack [D-RI], Sen. Markey, Edward J. [D-MA], Sen. Klobuchar, Amy [D-MN], Sen. Collins, Susan M. [R-ME]
Recent Actions
- 2025-05-06: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-05-06: Introduced in Senate
Bill Versions
- Ellie Helton, Lisa Colagrossi, Kristen Shafer Englert, Teresa Anne Lawrence, and Jennifer Sedney Focused Research Act — issued 2025-05-06 — PDF (6 pages)